These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11891818)

  • 1. Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma.
    Jyoko N; Kuroda J; Kimura S; Kobayashi Y; Yoshikawa T
    Am J Hematol; 2002 Mar; 69(3):234-5. PubMed ID: 11891818
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive natural killer cell leukemia/lymphoma: a comprehensive cytogenetic study by spectral karyotyping.
    Kuroda J; Kimura S; Akaogi T; Hayashi H; Nishida K; Kakazu N; Abe T
    Ann Hematol; 2000 Sep; 79(9):519-22. PubMed ID: 11043424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
    Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
    Siu LL; Wong KF; Chan JK; Kwong YL
    Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-like T-cell leukaemia/lymphoma.
    Gupta V; Mills MJ; Eden AG
    Br J Haematol; 2001 Dec; 115(3):490. PubMed ID: 11736928
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
    Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
    Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+gamma/delta T cell leukemia/lymphoma: clinical, immunophenotypic and molecular aspects in an unusual case.
    de Souza MH; Hassan R; Stefanoff CG; Maioli MC; Diamond HR; Renault IZ
    Haematologica; 2003 Aug; 88(8):ECR27. PubMed ID: 12935986
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
    Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
    Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of cytogenetic research in childhood acute lymphoblastic leukemia.
    Raimondi SC
    Blood; 1993 May; 81(9):2237-51. PubMed ID: 8481506
    [No Abstract]   [Full Text] [Related]  

  • 11. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56+ hematologic malignancies.
    Loughran TP
    Leuk Res; 1999 Jul; 23(7):675-6. PubMed ID: 10400189
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Shimizu N; Orita K
    Hum Cell; 2004 Jun; 17(2):85-92. PubMed ID: 15369140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-cell lymphomas and "natural killer". Histopathologic, immunologic and molecular aspects].
    Kanavaros P; Gaulard P
    Ann Pathol; 1998 Oct; 18(4):299-314. PubMed ID: 9827221
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphoid disorders other than common acute lymphoblastic leukemia: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():93-110. PubMed ID: 12744209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome Preparation for Acute Lymphoblastic Leukemia.
    Shago M
    Methods Mol Biol; 2017; 1541():19-31. PubMed ID: 27910011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural killer-like T-cell lymphoma/leukemia--a case report and literature review].
    Zhang FK; Wang HJ; Wu YH; Dong SX; Li HQ; Yang DL; Chen HS; Chu YL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):226-30. PubMed ID: 16875551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotyping.
    Wan TS; Ma SK; Chan GC; Ching LM; Ha SY; Chan LC
    Cancer Genet Cytogenet; 2000 Apr; 118(1):24-7. PubMed ID: 10731586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor gamma and delta junctional gene rearrangements as diagnostic and prognostic biomarker for T-cell acute lymphoblastic leukemia.
    Kode J; Dudhal N; Banavali S; Chiplunkar S
    Leuk Lymphoma; 2006 Apr; 47(4):769-70. PubMed ID: 16886283
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular genetics and malignant hemopathies. The current situation].
    Soler J
    Med Clin (Barc); 1992 Jan; 98(3):94-5. PubMed ID: 1552757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.